Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of hereditary thrombotic factors and comorbidities on the severity of COVID-19 disease.

European review for medical and pharmacological sciences - 1 Jan 2023

Kose M, Senkal N, Konyaoglu H, Emet A, Oyaci Y, Pehlivan S, Sayin G Y

Abstract excerpt

OBJECTIVE: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide and presents critical challenges for public health. Due to its chronic and systemic course, COVID-19 is currently accepted as a multi-systemic infectious disease. Here we explore the possible association between disease course and hereditary thrombotic factors and comorbidities. PATIENTS AND METHODS: The patients admitted to the COVID-19...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Comorbidity
Share to COVID-19
Share to Fibrinogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Patient Acuity

Share to Thrombophilia

Share to Thrombosis

Source

Identifiers

PMID: 36647888
DOI: 10.26355/eurrev_202301_30893

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of hereditary thrombotic factors and comorbidities on the severity of COVID-19 disease.PMID 36647888Read ↗

Thrombophilia genetic mutations and their relation to disease severity among patients with COVID-19.Semantic proximity Read ↗

Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.Semantic proximity Read ↗

Effect of Hereditary Thrombophilia on the Clinical Severity of Covid-19 PneumoniaSemantic proximity Read ↗

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalitySemantic proximity Read ↗

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.Semantic proximity Read ↗

Hereditary thrombophilia as a possible risk factor for severe disease in COVID-19: a case series.Semantic proximity Read ↗

Genetics Insight for COVID-19 Susceptibility and Severity: A Review.Semantic proximity Read ↗

Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID‐19 patients: A pilot studySemantic proximity Read ↗

Correlating COVID-19 severity with biomarker profiles and patient prognosisSemantic proximity Read ↗

A Case-Control Study of Factor V Leiden G1691A and MTHFR A1298C Polymorphisms and Clinical Outcomes in Patients With COVID-19.Semantic proximity Read ↗

COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseasesSemantic proximity Read ↗

Polygenic predisposition to venous thromboembolism is associated with increased COVID-19 positive testing ratesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.